Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Davidoff

Showing results (31-40 of 337) with videos related to

Pageof 34
Sort By:
Molecular Cancer|July 19, 2025
From preneoplastic lesion to heterogenous tumor: recent insights into hepatoblastoma biology and therapeutic opportunitiesJun Yang, Andrew M Davidoff, Andrew J Murphy
Expert Review of Hematology|September 24, 2011
Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challengesDeepak Raj, Andrew M Davidoff, Amit C Nathwani
Human Gene Therapy|March 30, 2016
Gene Therapy for HemophiliaArthur W Nienhuis, Amit C Nathwani, Andrew M Davidoff
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2023
Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapyMark A Brimble, Stephen M Winston, Andrew M Davidoff
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2017
Gene Therapy for HemophiliaArthur W Nienhuis, Amit C Nathwani, Andrew M Davidoff
British Journal of Haematology|December 21, 2004
A review of gene therapy for haematological disordersAmit C Nathwani, Andrew M Davidoff, David C Linch
World Journal of Hepatology|July 25, 2015
Hepatic metastatic disease in pediatric and adolescent solid tumorsIsrael Fernandez-Pineda, John A Sandoval, Andrew M Davidoff
The New England Journal of Medicine|August 20, 2025
AAV Gene Therapy in Severe Hemophilia B. ReplyUlrike M Reiss, Andrew M Davidoff, Amit C Nathwani
Current Hematology Reports|August 7, 2003
Current status of gene therapy for hemophiliaAmit C Nathwani, Arthur W Nienhuis, Andrew M Davidoff
Technology in Cancer Research & Treatment|July 21, 2005
Delivery of antiangiogenic agents for cancer gene therapyPaxton V Dickson, Amit C Nathwani, Andrew M Davidoff
Pageof 34

Showing results (31-40 of 337) with videos related to

Sort By:
Pageof 34
Molecular Cancer|July 19, 2025
From preneoplastic lesion to heterogenous tumor: recent insights into hepatoblastoma biology and therapeutic opportunitiesJun Yang, Andrew M Davidoff, Andrew J Murphy
Expert Review of Hematology|September 24, 2011
Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challengesDeepak Raj, Andrew M Davidoff, Amit C Nathwani
Human Gene Therapy|March 30, 2016
Gene Therapy for HemophiliaArthur W Nienhuis, Amit C Nathwani, Andrew M Davidoff
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2023
Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapyMark A Brimble, Stephen M Winston, Andrew M Davidoff
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2017
Gene Therapy for HemophiliaArthur W Nienhuis, Amit C Nathwani, Andrew M Davidoff
British Journal of Haematology|December 21, 2004
A review of gene therapy for haematological disordersAmit C Nathwani, Andrew M Davidoff, David C Linch
World Journal of Hepatology|July 25, 2015
Hepatic metastatic disease in pediatric and adolescent solid tumorsIsrael Fernandez-Pineda, John A Sandoval, Andrew M Davidoff
The New England Journal of Medicine|August 20, 2025
AAV Gene Therapy in Severe Hemophilia B. ReplyUlrike M Reiss, Andrew M Davidoff, Amit C Nathwani
Current Hematology Reports|August 7, 2003
Current status of gene therapy for hemophiliaAmit C Nathwani, Arthur W Nienhuis, Andrew M Davidoff
Technology in Cancer Research & Treatment|July 21, 2005
Delivery of antiangiogenic agents for cancer gene therapyPaxton V Dickson, Amit C Nathwani, Andrew M Davidoff
Pageof 34